Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities
Net (loss) income	$ (29,267)	$ 9,840	$ 13,789
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation	4,673	3,034	1,385
Amortization of deferred financing costs	143	143	181
Amortization of right-of-use assets	2,446	1,274	0
Share based compensation expense	28,671	25,448	3,524
Allowance for credit losses, net	736	(22)	0
Loss on disposal of fixed assets	94	69	237
Loss on extinguishment of debt	0	0	648
Loss on change in fair value of warrant liabilities	0	0	3,317
Changes in:
Accounts receivable	(17,030)	(14,361)	(16,706)
Inventories	(11,688)	(10,488)	(6,644)
Prepaid expenses, deposits and other assets	580	(3,430)	(2,458)
Accounts payable	1,140	3,514	498
Payroll-related accruals, accrued expenses and other liabilities	10,691	25,992	4,141
Operating lease liabilities	(923)	(772)	0
Lease prepayments for lessor's owned leasehold improvements	(4,238)	(14,755)	0
Net cash (used in) provided by operating activities	(13,972)	25,486	1,912
Cash flows from investing activities
Purchase of property and equipment	(9,951)	(13,645)	(5,460)
Purchases of marketable securities	(489,605)	(134,377)	(49,977)
Maturities of marketable securities	312,600	97,000	0
Purchases of other investments	(8,260)	0	0
Net cash used in investing activities	(195,216)	(51,022)	(55,437)
Cash flows from financing activities
Proceeds from issuance of common stock in public offering, net of issuance costs	174,395	0	164,361
Proceeds from issuance of common stock under employee stock purchase plan	8,422	5,558	0
Proceeds from exercise of stock option and warrants	810	869	471
Payment of taxes related to vested restricted stock units	(6,489)	(2,354)	(25)
Proceeds from notes payable	0	0	10,000
Repayments of notes payable	0	0	(30,250)
Debt financing costs	0	0	(442)
Net cash provided by financing activities	177,138	4,073	144,115
Effect of foreign exchange rate on cash and cash equivalents	(480)	(402)	0
Net (decrease) increase in cash	(32,530)	(21,865)	90,590
Cash and cash equivalents beginning of period	92,752	114,617	24,027
Cash and cash equivalents end of period	60,222	92,752	114,617
Supplemental disclosures of cash flow information:
Cash paid for income taxes	3,417	472	154
Cash paid for interest	151	151	999
Noncash investing and financing:
Lease liabilities arising from obtaining new right-of-use assets	3,947	28,648	0
Common stock issued on conversion of convertible preferred stock	0	0	54,170
Common stock warrants issued on conversion of preferred stock warrants and the reclassification of the warrant liability	0	0	4,486
Deferred initial public offering cost recorded to additional paid in capital	$ 0	$ 0	$ 1,382